Clincosm LogoSign in Get a demo

InSeCur: Interplay of Self-Criticism and Symptom Severity Over the Course of In-patient Psychotherapeutic Treatment

Sponsor
University Hospital Heidelberg (Other)
Overall Status
Completed
CT.gov ID
NCT05120453
Collaborator
(none)
2,778
Enrollment
74.9
Actual Duration (Months)

Study Details

Study Description

Brief Summary

The purpose of this study is to assess the interplay between self-criticism and symptom severity in patients undergoing psychotherapeutic treatment.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Participants are recruited at the University Clinic Heidelberg at the beginning of their (usually) 8-week in-patient treatment, consisting of somatic and psychotherapeutic aspects. After informed consent, patients routinely fill out weekly questionnaires about their self-criticism and their symptom severity. The overall aim of this study is to disentangle stable (between-person) effects of both self-criticism and symptom severity from within-person effects happening over time in order to better understand what drives what, or in other words, their dynamic interplay. The analysis is based on the weekly assessment of the patients. All patients receive the standard care of the in-patient treatment.

    Study Design

    Study Type:
    Observational [Patient Registry]
    Actual Enrollment :
    2778 participants
    Observational Model:
    Ecologic or Community
    Time Perspective:
    Prospective
    Official Title:
    Assessment of the Interplay Between Self-critisim and Symptom Severity Over the Course of In-patient Psychotherapeutic Treatment
    Actual Study Start Date :
    Jan 1, 2015
    Actual Primary Completion Date :
    Mar 30, 2021
    Actual Study Completion Date :
    Mar 30, 2021

    Outcome Measures

    Primary Outcome Measures

    1. SCL-K11 [Weekly Assessments over the course of the in-patient treatment (usually about 8 weeks)]

      Symptom Check-List German Short Version with 11 Items

    2. TDEQ-12 (Subscale Self-Criticism [Weekly Assessments over the course of the in-patient treatment (usually about 8 weeks)]

      Theoretical Depressive Experiences Questionnaire German Short Version with 12 Items: Subscale Self-Criticism

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    17 Years and Older
    Sexes Eligible for Study:
    All
    Inclusion Criteria:
    • Undergoing in-patient treatment at the University Clinic Heidelberg (Klinik für Allgemeine Innere Medizin und Psychosomatik)
    Exclusion Criteria:
    • none

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • University Hospital Heidelberg

    Investigators

    • Study Chair: Ulrike Dinger, Prof, University Hospital Heidelberg

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Simone Jennissen, Principal Investigator, University Hospital Heidelberg
    ClinicalTrials.gov Identifier:
    NCT05120453
    Other Study ID Numbers:
    • ST-TDEQSCL-2021
    First Posted:
    Nov 15, 2021
    Last Update Posted:
    Nov 15, 2021
    Last Verified:
    Nov 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No

    Study Results

    No Results Posted as of Nov 15, 2021